Trump Launches TrumpRx Portal to List Discounted Brand Drugs
TrumpRx lists 43 drugs with coupon codes for cash-paying patients, including Wegovy at $199 for initial months, according to the White House.
Overview
President Donald Trump unveiled TrumpRx at a 7 p.m. ET White House event on Feb. 5, 2025, launching a government-hosted website that lists 43 discounted brand-name drugs and provides coupon codes, officials said.
The site follows 'most favored nation' pricing agreements the administration says it secured with at least 16 drugmakers, and the platform directs users to manufacturers' sites or participating pharmacies rather than selling drugs directly, records show.
Juliette Cubanski, deputy director for Medicare Policy at KFF, said the platform's primary beneficiaries will be uninsured and cash-paying patients and may not lower costs for the roughly 85 percent of Americans with prescription coverage, according to experts.
The initial list includes Wegovy offered at $199 for the first two months and Gonal-F at $252, and the White House said discounts apply to 43 medications though only five companies' drugs were live on the site as of launch, records show.
Public Citizen has filed a Freedom of Information Act lawsuit seeking internal documents about the TrumpRx deals, and officials said the administration plans to add more drugs while questions remain about whether purchases count toward insurance cost-sharing.
Analysis
Center-leaning sources present a balanced account: they relay White House claims and price examples while pairing them with independent expert caveats (cash-only limits, few drugs, no deductible credit). Editorial choices—equal placement of administration statements and skeptical analysis, factual lists of drugs, and expert context—favor neutral, evidence-focused coverage rather than advocacy.
FAQ
TrumpRx.gov is a government-hosted website launched by President Trump that lists 43 discounted brand-name drugs with coupon codes for cash-paying patients, directing them to manufacturers' sites or pharmacies via 'most favored nation' pricing deals with drugmakers like AstraZeneca, Eli Lilly, and Novo Nordisk.
The launch features drugs from five manufacturers: AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk, and Pfizer, including Wegovy at $199 for the first two months, Gonal-F at $252, Bevespi Aerosphere from $458 to $51, and Airsupra from $504 to $201.
Primary beneficiaries are uninsured and cash-paying patients; it may not lower costs for the 85% of Americans with prescription coverage, and questions remain if purchases count toward insurance cost-sharing.
MFN agreements with at least 16 drugmakers ensure U.S. cash-paying patients pay prices aligned with the lowest in other developed nations, secured in exchange for tariff exemptions, covering drugs like GLP-1 weight-loss medications.
TrumpRx was unveiled at a White House event on February 5, 2026, at 7 p.m. ET, following announcements in late 2025.
